Investigating novel Streptomyces bacteriophage endolysins as potential antimicrobial agents
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.01170-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Jindanuch Maneekul und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of North Texas, Denton, Texas, USA. Hauptthemen laut MEDLINE: Endopeptidases, Streptomyces, Bacteriophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As antibiotic resistance has become a major global threat, the World Health Organization (WHO) has urgently called for alternative strategies for control of bacterial infections. Endolysin, a phage-encoded protein, can degrade bacterial peptidoglycan (PG) and disrupt bacterial growth. According to the WHO, there are only three endolysin products currently in clinical phase development. In this study, we explore novel endolysins from Streptomyces phages as only a few of them have been experimentally characterized. Using several bioinformatics tools, we identified nine different functional domain combinations from 250 Streptomyces phages putative endolysins. LazerLemon gp35 (CHAP; LL35lys), Nabi gp26 (amidase; Nb26lys), and Tribute gp42 (PGRP/amidase; Tb42lys) were selected for experimental studies. We hypothesized that (i) the proteins of interest will have the ability to degrade purified PG, and (ii) the proteins will have potential antimicrobial activity against bacteria from families of importance in antibiotic resistance, such as ESKAPE safe relatives ( Enterococcus raffinosus , Staphylococcus epidermidis , Klebsiella aerogenes , Acinetobacter baylyi , Pseudomonas putida , and Escherichia coli ). LL35lys, Nb26lys, and Tb42lys exhibit PG-degrading activity on zymography and hydrolysis assay. The enzymes (100 µg/mL) can reduce PG turbidity to 32%–40%. The killing assay suggests that Tb42lys has a broader range ( E. coli , P. putida , A. baylyi and K. aerogenes ). While Nb26lys better attacks Gram-negative than -positive bacteria, LL35lys can only reduce the growth of the Gram-positive ESKAPE strains but does so effectively with a low MIC 90 of 2 µg/mL. A higher concentration (≥300 µg/mL) of Nb26lys is needed to inhibit P. putida and K. aerogenes . From 250 putative endolysins, bioinformatic methods were used to select three putative endolysins for cloning and study: LL35lys, Nb26lys, and Tb42lys. All have shown PG-degrading activity, a critical function of endolysin. With a low MIC, LL35lys shows activity for the Gram-positive ESKAPE strains, while Nb26lys and Tb42lys are active against the Gram negatives. Therefore, endolysins from Streptomyces phages have potential as possible antimicrobial agents against ESKAPE bacteria. IMPORTANCE As antibiotic resistance has become a major global threat, the World Health Organization (WHO) has urgently called for alternative strategies for control of bacterial infections. Endolysin, a phage-encoded protein, can degrade bacterial peptidoglycan in the bacterial cell wall and disrupt bacterial growth. According to the WHO, there are only three endolysin products currently in clinical phase development. In this study we explored novel endolysins from Streptomyces phages as only a few of them have been experimentally characterized. Using several bioinformatics tools, we identified nine different combinations of functional enzymatic domain types from 250 Streptomyces bacteriophages possible endolysins. From these, three potential endolysins were selected for experimental characterization. All three showed positive results in degrading cell wall material and disrupting bacterial growth, indicating their potential as possible antimicrobial agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, University of North Texas, Denton, Texas, USA.
ORCID-Profile: Lee E Hughes
Zitieren
APA
Maneekul, J., Chiaha, A., Hughes, R., Labry, F., Saito, J., Almendares, M., Banda, B. N., Lopez, L., McGaskey, N., Miranda, M., Rana, J., Zadeh, B. R., & Hughes, L. E. (2025). Investigating novel Streptomyces bacteriophage endolysins as potential antimicrobial agents. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01170-24
Vancouver
Maneekul J, Chiaha A, Hughes R, Labry F, Saito J, Almendares M, et al. Investigating novel Streptomyces bacteriophage endolysins as potential antimicrobial agents. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01170-24
BibTeX
@article{Maneekul2025,
author = {Maneekul, Jindanuch and Chiaha, Amanda and Hughes, Rachel and Labry, Faith and Saito, Joshua and Almendares, Matthew and Banda, Brenda N and Lopez, Leslie and McGaskey, Nyeomi and Miranda, Melizza and Rana, Jenil and Zadeh, Brandon R and Hughes, Lee E},
title = {Investigating novel Streptomyces bacteriophage endolysins as potential antimicrobial agents},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.01170-24}
}
EUVIMED